Cargando…
EIF4G1 Is a Potential Prognostic Biomarker of Breast Cancer
Background: Breast cancer (BRCA) is one of the most common cancers in women worldwide and a leading cause of death from malignancy. This study was designed to identify a novel biomarker for prognosticating the survival of BRCA patients. Methods: The prognostic potential of eukaryotic translation ini...
Autores principales: | Li, Kun, Tan, Guangqing, Zhang, Xin, Lu, Weiyu, Ren, Jingyi, Si, Yuewen, Adu-Gyamfi, Enoch Appiah, Li, Fangfang, Wang, Yingxiong, Xie, Biao, Wang, Meijiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776011/ https://www.ncbi.nlm.nih.gov/pubmed/36551184 http://dx.doi.org/10.3390/biom12121756 |
Ejemplares similares
-
RB1 Is an Immune-Related Prognostic Biomarker for Ovarian Cancer
por: Xie, Biao, et al.
Publicado: (2022) -
Elafin is related to immune infiltration and could predict the poor prognosis in ovarian cancer
por: Lu, Weiyu, et al.
Publicado: (2023) -
The PNA mouse may be the best animal model of polycystic ovary syndrome
por: Ren, Jingyi, et al.
Publicado: (2022) -
LncRNA functional annotation with improved false discovery rate achieved by disease associations
por: Wang, Yongheng, et al.
Publicado: (2021) -
The impact of bisphenol A on the placenta
por: Adu-Gyamfi, Enoch Appiah, et al.
Publicado: (2022)